Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat.

Diack C, Ackaert O, Ploeger BA, van der Graaf PH, Gurrell R, Ivarsson M, Fairman D.

J Pharmacokinet Pharmacodyn. 2011 Dec;38(6):697-711. doi: 10.1007/s10928-011-9215-3. Epub 2011 Sep 10.

2.

Studies on wakefulness-promoting effect of memantine in rats.

Ishida T, Obara Y, Kamei C.

Behav Brain Res. 2010 Jan 20;206(2):274-8. doi: 10.1016/j.bbr.2009.09.025. Epub 2009 Sep 23.

PMID:
19781580
3.

In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.

De Clerck F, Van de Water A, D'Aubioul J, Lu HR, van Rossem K, Hermans A, Van Ammel K.

Fundam Clin Pharmacol. 2002 Apr;16(2):125-40. Review.

PMID:
12031065
4.

Clinical neuropharmacology of sleep disorders.

Manfredi RL, Kales A.

Semin Neurol. 1987 Sep;7(3):286-95. Review.

PMID:
3332464
5.

Entropy-based measures for quantifying sleep-stage transition dynamics: relationship to sleep fragmentation and daytime sleepiness.

Kirsch MR, Monahan K, Weng J, Redline S, Loparo KA.

IEEE Trans Biomed Eng. 2012 Mar;59(3):787-96. doi: 10.1109/TBME.2011.2179032. Epub 2011 Dec 9.

PMID:
22167554
6.

Effects of anti-dementia drugs on morphine-induced somnolence.

Ishida T, Suga A, Akagi M, Kamei C.

Biol Pharm Bull. 2009 Nov;32(11):1862-5.

7.

Prolonged sedation with propofol in the rat does not result in sleep deprivation.

Tung A, Lynch JP, Mendelson WB.

Anesth Analg. 2001 May;92(5):1232-6.

PMID:
11323352
8.

The effect of sleep fragmentation on daytime function.

Stepanski EJ.

Sleep. 2002 May 1;25(3):268-76.

PMID:
12003157
9.

Effects of method, duration, and sleep stage on rebounds from sleep deprivation in the rat.

Rechtschaffen A, Bergmann BM, Gilliland MA, Bauer K.

Sleep. 1999 Feb 1;22(1):11-31. Review.

PMID:
9989363
10.

Long term effects of sleep deprivation on the mammalian circadian pacemaker.

Deboer T, Détári L, Meijer JH.

Sleep. 2007 Mar;30(3):257-62.

PMID:
17425221
11.

A comparison of doubly hierarchical discriminant analyses for multiple class longitudinal data from EEG experiments.

Wouters K, Abrahantes JC, Molenberghs G, Ahnaou A, Drinkenburg WH, Bijnens L.

J Biopharm Stat. 2008;18(6):1120-35. doi: 10.1080/10543400802369111.

PMID:
18991112
12.

Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.

Paterson LM, Wilson SJ, Nutt DJ, Hutson PH, Ivarsson M.

J Psychopharmacol. 2009 Jul;23(5):475-86. doi: 10.1177/0269881109104846. Epub 2009 Apr 24.

PMID:
19395429
13.

A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.

Paterson LM, Wilson SJ, Nutt DJ, Hutson PH, Ivarsson M.

Psychopharmacology (Berl). 2007 May;191(4):943-50. Epub 2007 Jan 16.

PMID:
17225163
14.

Selective and total sleep deprivation: effect on the sleep EEG in the rat.

Endo T, Schwierin B, Borbély AA, Tobler I.

Psychiatry Res. 1997 Feb 7;66(2-3):97-110.

PMID:
9075274
15.

Modeling sleep data for a new drug in development using markov mixed-effects models.

Kjellsson MC, Ouellet D, Corrigan B, Karlsson MO.

Pharm Res. 2011 Oct;28(10):2610-27. doi: 10.1007/s11095-011-0490-x. Epub 2011 Jun 17.

PMID:
21681607
16.

In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.

Gilmour G, Broad LM, Wafford KA, Britton T, Colvin EM, Fivush A, Gastambide F, Getman B, Heinz BA, McCarthy AP, Prieto L, Shanks E, Smith JW, Taboada L, Edgar DM, Tricklebank MD.

Neuropharmacology. 2013 Jan;64:224-39. doi: 10.1016/j.neuropharm.2012.07.030. Epub 2012 Aug 1.

PMID:
22884720
17.

Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.

Bizzotto R, Zamuner S, De Nicolao G, Karlsson MO, Gomeni R.

J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):137-55. doi: 10.1007/s10928-009-9148-2. Epub 2010 Jan 6.

PMID:
20052524
18.

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview.

Comella CL.

J Neural Transm Suppl. 2006;(70):349-55. Review.

PMID:
17017552
19.

Reductions in paradoxical sleep time in adult rats treated neonatally with low dose domoic acid.

Gill DA, Bastlund JF, Anderson NJ, Tasker RA.

Behav Brain Res. 2009 Dec 28;205(2):564-7. doi: 10.1016/j.bbr.2009.07.018. Epub 2009 Jul 23.

PMID:
19631692
20.

Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.

Kitka T, Adori C, Katai Z, Vas S, Molnar E, Papp RS, Toth ZE, Bagdy G.

Neurochem Int. 2011 Oct;59(5):686-94. doi: 10.1016/j.neuint.2011.06.015. Epub 2011 Jun 28.

PMID:
21740944

Supplemental Content

Support Center